109 related articles for article (PubMed ID: 3332681)
1. Ganglioside administration in retinitis pigmentosa.
Newsome DA; Dorsey FC; May JG; Bergsma DR; Bazan NG
J Ocul Pharmacol; 1987; 3(4):323-32. PubMed ID: 3332681
[TBL] [Abstract][Full Text] [Related]
2. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289].
Bahrami H; Melia M; Dagnelie G
BMC Ophthalmol; 2006 Jun; 6():23. PubMed ID: 16759390
[TBL] [Abstract][Full Text] [Related]
3. Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.
Birch DG; Bernstein PS; Iannacone A; Pennesi ME; Lam BL; Heckenlively J; Csaky K; Hartnett ME; Winthrop KL; Jayasundera T; Hughbanks-Wheaton DK; Warner J; Yang P; Fish GE; Teske MP; Sklaver NL; Erker L; Chegarnov E; Smith T; Wahle A; VanVeldhuisen PC; McCormack J; Lindblad R; Bramer S; Rose S; Zilliox P; Francis PJ; Weleber RG
JAMA Ophthalmol; 2018 Aug; 136(8):849-856. PubMed ID: 29879277
[TBL] [Abstract][Full Text] [Related]
4. Treatment with 9-cis β-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial.
Rotenstreich Y; Belkin M; Sadetzki S; Chetrit A; Ferman-Attar G; Sher I; Harari A; Shaish A; Harats D
JAMA Ophthalmol; 2013 Aug; 131(8):985-92. PubMed ID: 23700011
[TBL] [Abstract][Full Text] [Related]
5. Chlorogenic acid supplementation improves multifocal electroretinography in patients with retinitis pigmentosa.
Shin JY; Yu HG
J Korean Med Sci; 2014 Jan; 29(1):117-21. PubMed ID: 24431915
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of visual function in carriers of X-linked recessive retinitis pigmentosa.
Grover S; Fishman GA; Anderson RJ; Lindeman M
Ophthalmology; 2000 Feb; 107(2):386-96. PubMed ID: 10690843
[TBL] [Abstract][Full Text] [Related]
7. The effects of acetazolamide on visual function in retinitis pigmentosa.
Greenstein VC; Holopigian K; Siderides E; Seiple W; Carr RE
Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):269-73. PubMed ID: 8425835
[TBL] [Abstract][Full Text] [Related]
8. The adverse effects of valproic acid on visual functions in the treatment of retinitis pigmentosa.
Totan Y; Güler E; Yüce A; Dervişogulları MS
Indian J Ophthalmol; 2017 Oct; 65(10):984-988. PubMed ID: 29044065
[TBL] [Abstract][Full Text] [Related]
9. NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study.
Falsini B; Iarossi G; Chiaretti A; Ruggiero A; Manni L; Galli-Resta L; Corbo G; Abed E
J Transl Med; 2016 Jan; 14():8. PubMed ID: 26748988
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
Berson EL; Rosner B; Sandberg MA; Hayes KC; Nicholson BW; Weigel-DiFranco C; Willett W
Arch Ophthalmol; 1993 Jun; 111(6):761-72. PubMed ID: 8512476
[TBL] [Abstract][Full Text] [Related]
11. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
Nagy D; Schönfisch B; Zrenner E; Jägle H
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
[TBL] [Abstract][Full Text] [Related]
13. Longevity of visual improvements following transcorneal electrical stimulation and efficacy of retreatment in three individuals with retinitis pigmentosa.
Bittner AK; Seger K
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):299-306. PubMed ID: 29222719
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Brockhurst RJ; Hayes KC; Johnson EJ; Anderson EJ; Johnson CA; Gaudio AR; Willett WC; Schaefer EJ
Arch Ophthalmol; 2010 Apr; 128(4):403-11. PubMed ID: 20385935
[TBL] [Abstract][Full Text] [Related]
15. A new method of treatment of retinitis pigmentosa/pigmentary abiotrophy.
Katznelson LA; Khoroshilova-Maslova IP; Eliseyeva RF
Ann Ophthalmol; 1990 May; 22(5):167-72. PubMed ID: 2369027
[TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
[TBL] [Abstract][Full Text] [Related]
17. Multifocal electroretinography in retinitis pigmentosa.
Seeliger M; Kretschmann U; Apfelstedt-Sylla E; Rüther K; Zrenner E
Am J Ophthalmol; 1998 Feb; 125(2):214-26. PubMed ID: 9467449
[TBL] [Abstract][Full Text] [Related]
18. Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study.
Pasantes-Morales H; Quiroz H; Quesada O
Metab Brain Dis; 2002 Sep; 17(3):183-97. PubMed ID: 12322788
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of topical treatment with an alpha2-agonist in patients with retinal dystrophies.
Merin S; Obolensky A; Farber MD; Chowers I
J Ocul Pharmacol Ther; 2008 Feb; 24(1):80-6. PubMed ID: 18201138
[TBL] [Abstract][Full Text] [Related]
20. Concentric retinitis pigmentosa: clinicopathologic correlations.
Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
